Get In Touch
Composition : BICTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDE
by MYLAN PHARMACEUTICALS PVT LTD
Composition : BICTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDE
by HETERO HEALTHCARE LTD
BICTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDE
MYLAN PHARMACEUTICALS PVT LTD
HIV-1 infection
30 TABLET(s) IN A BOTTLE
Tablet
Therapeutic classification : Antiviral agents
Taftrio Tablet is a prescription antiretroviral medication used for the treatment of HIV-1 infection. It contains a combination of three active ingredients Bictegravir, Emtricitabine, and Tenofovir Alafenamide which work together to control the replication of the human immunodeficiency virus (HIV) in the body. By lowering the viral load, this medicine helps strengthen the immune system and reduces the risk of HIV-related complications and opportunistic infections.
When taken regularly as prescribed by a healthcare professional, Taftrio Tablet can help slow the progression of HIV disease and improve overall quality of life for people living with HIV. However, it is important to note that this medication does not cure HIV but helps manage the infection effectively as part of long-term antiretroviral therapy (ART).
Taftrio Tablet helps manage HIV-1 infection by reducing the amount of virus (viral load) in the body and preventing it from multiplying. This action helps strengthen the immune system, slows the progression of HIV, and lowers the risk of opportunistic infections and HIV-related complications. When taken regularly as prescribed, it can help people living with HIV maintain better overall health and improve their quality of life.
Like all medicines, Alcibicla Tablets may cause side effects in some people. These side effects can range from mild to serious. It is important to be aware of them and consult a healthcare professional if any symptoms persist or worsen.
These are usually mild and may improve as your body adjusts to the medicine:
If you experience any severe or persistent symptoms, seek medical advice immediately.
Do not use it if you are allergic to Bictegravir, Emtricitabine, or Tenofovir Alafenamide.
Use with caution in patients with liver, kidney, or pancreas problems.
May cause immune reconstitution syndrome during early HIV treatment.
Inform your doctor about other medicines you are taking.
Pregnancy and breastfeeding: Use only if advised by a doctor; breastfeeding is not recommended.
Store at room temperature (below 30°C).
Keep in a cool, dry place away from sunlight and moisture.
Taftrio Tablet is prescribed for the treatment of HIV-1 infection. It helps control the virus in the body and supports the immune system when used as part of antiretroviral therapy (ART).
It contains Bictegravir, Emtricitabine, and Tenofovir Alafenamide, which work together to block the replication of the HIV virus, reducing the viral load and slowing the progression of the infection.
No, Taftrio Tablet does not cure HIV, but it helps control the virus and reduces the risk of HIV-related complications when taken regularly.
It is generally prescribed for adults and certain adolescents with HIV-1 infection, as recommended by a healthcare professional.
If you miss a dose, take it as soon as you remember. If it is close to the next scheduled dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose.
Although uncommon, serious side effects may include liver problems, kidney issues, pancreatitis, or severe allergic reactions. Immediate medical attention is required if severe symptoms occur.
Yes, it may interact with certain prescription drugs, over-the-counter medicines, and herbal supplements. Always inform your doctor about all medications you are taking.
This medication is generally not recommended during early pregnancy unless advised by a healthcare provider. Women of childbearing age should use effective contraception.
Breastfeeding is not recommended for women with HIV, as the virus can be transmitted to the baby through breast milk.
Yes, doctors may monitor blood counts, kidney function, liver function, and bone health regularly to ensure the treatment remains safe and effective.
Therapeutic classification : Antiviral agents
Taftrio Tablet is a prescription antiretroviral medication used for the treatment of HIV-1 infection. It contains a combination of three active ingredients Bictegravir, Emtricitabine, and Tenofovir Alafenamide which work together to control the replication of the human immunodeficiency virus (HIV) in the body. By lowering the viral load, this medicine helps strengthen the immune system and reduces the risk of HIV-related complications and opportunistic infections.
When taken regularly as prescribed by a healthcare professional, Taftrio Tablet can help slow the progression of HIV disease and improve overall quality of life for people living with HIV. However, it is important to note that this medication does not cure HIV but helps manage the infection effectively as part of long-term antiretroviral therapy (ART).
Taftrio Tablet helps manage HIV-1 infection by reducing the amount of virus (viral load) in the body and preventing it from multiplying. This action helps strengthen the immune system, slows the progression of HIV, and lowers the risk of opportunistic infections and HIV-related complications. When taken regularly as prescribed, it can help people living with HIV maintain better overall health and improve their quality of life.
Like all medicines, Alcibicla Tablets may cause side effects in some people. These side effects can range from mild to serious. It is important to be aware of them and consult a healthcare professional if any symptoms persist or worsen.
These are usually mild and may improve as your body adjusts to the medicine:
If you experience any severe or persistent symptoms, seek medical advice immediately.
Do not use it if you are allergic to Bictegravir, Emtricitabine, or Tenofovir Alafenamide.
Use with caution in patients with liver, kidney, or pancreas problems.
May cause immune reconstitution syndrome during early HIV treatment.
Inform your doctor about other medicines you are taking.
Pregnancy and breastfeeding: Use only if advised by a doctor; breastfeeding is not recommended.
Store at room temperature (below 30°C).
Keep in a cool, dry place away from sunlight and moisture.
Taftrio Tablet is prescribed for the treatment of HIV-1 infection. It helps control the virus in the body and supports the immune system when used as part of antiretroviral therapy (ART).
It contains Bictegravir, Emtricitabine, and Tenofovir Alafenamide, which work together to block the replication of the HIV virus, reducing the viral load and slowing the progression of the infection.
No, Taftrio Tablet does not cure HIV, but it helps control the virus and reduces the risk of HIV-related complications when taken regularly.
It is generally prescribed for adults and certain adolescents with HIV-1 infection, as recommended by a healthcare professional.
If you miss a dose, take it as soon as you remember. If it is close to the next scheduled dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose.
Although uncommon, serious side effects may include liver problems, kidney issues, pancreatitis, or severe allergic reactions. Immediate medical attention is required if severe symptoms occur.
Yes, it may interact with certain prescription drugs, over-the-counter medicines, and herbal supplements. Always inform your doctor about all medications you are taking.
This medication is generally not recommended during early pregnancy unless advised by a healthcare provider. Women of childbearing age should use effective contraception.
Breastfeeding is not recommended for women with HIV, as the virus can be transmitted to the baby through breast milk.
Yes, doctors may monitor blood counts, kidney function, liver function, and bone health regularly to ensure the treatment remains safe and effective.
Sourced from Manufacturers
Air Express Delivery
Trusted Medicines
Get Up to 85% Off
